GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » eFFECTOR Therapeutics Inc (STU:LWK) » Definitions » FCF Yield %

eFFECTOR Therapeutics (STU:LWK) FCF Yield % : -438.25 (As of Jun. 06, 2024)


View and export this data going back to 2021. Start your Free Trial

What is eFFECTOR Therapeutics FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, eFFECTOR Therapeutics's Trailing 12-Month Free Cash Flow is €-27.07 Mil, and Market Cap is €29.23 Mil. Therefore, eFFECTOR Therapeutics's FCF Yield % for today is -438.25%.

The historical rank and industry rank for eFFECTOR Therapeutics's FCF Yield % or its related term are showing as below:

STU:LWK' s FCF Yield % Range Over the Past 10 Years
Min: -2398.31   Med: -215.52   Max: -1.7
Current: -438.25


During the past 4 years, the highest FCF Yield % of eFFECTOR Therapeutics was -1.70%. The lowest was -2398.31%. And the median was -215.52%.

STU:LWK's FCF Yield % is ranked worse than
95.94% of 1553 companies
in the Biotechnology industry
Industry Median: -14.28 vs STU:LWK: -438.25

eFFECTOR Therapeutics's FCF Margin % for the quarter that ended in Mar. 2024 was 0.00%.


eFFECTOR Therapeutics FCF Yield % Historical Data

The historical data trend for eFFECTOR Therapeutics's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

eFFECTOR Therapeutics FCF Yield % Chart

eFFECTOR Therapeutics Annual Data
Trend Dec20 Dec21 Dec22 Dec23
FCF Yield %
- -7.75 -154.65 -

eFFECTOR Therapeutics Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -209.33 -74.50 -83.07 - -

Competitive Comparison of eFFECTOR Therapeutics's FCF Yield %

For the Biotechnology subindustry, eFFECTOR Therapeutics's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


eFFECTOR Therapeutics's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, eFFECTOR Therapeutics's FCF Yield % distribution charts can be found below:

* The bar in red indicates where eFFECTOR Therapeutics's FCF Yield % falls into.



eFFECTOR Therapeutics FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

eFFECTOR Therapeutics's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-27.186 / 0
=N/A%

eFFECTOR Therapeutics's annualized FCF Yield % for the quarter that ended in Mar. 2024 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-6.696 * 4 / 0
=N/A%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


eFFECTOR Therapeutics FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


eFFECTOR Therapeutics FCF Yield % Related Terms

Thank you for viewing the detailed overview of eFFECTOR Therapeutics's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


eFFECTOR Therapeutics (STU:LWK) Business Description

Traded in Other Exchanges
Address
142 North Cedros Avenue, Suite B, Solana Beach, CA, USA, 92075
eFFECTOR Therapeutics Inc is a clinical-stage biopharmaceutical company focused on pioneering the development of a new class of oncology drugs referred to as selective translation regulator inhibitors (STRIs).

eFFECTOR Therapeutics (STU:LWK) Headlines

No Headlines